Works matching IS 03125963 AND DT 2023 AND VI 62 AND IP 10

Results: 10

Imeglimin: A Clinical Pharmacology Review.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1393, doi. 10.1007/s40262-023-01301-y

By:

Chevalier, Clémence;
Fouqueray, Pascale;
Bolze, Sébastien

Publication type:

Article

Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1365, doi. 10.1007/s40262-023-01302-x

By:

Murray, Michael

Publication type:

Article

Population Pharmacokinetic Analysis of Follicle-Stimulating Hormone During Ovarian Stimulation: Relation with Weight, Prolactin and Gene Polymorphism in THADA and ADIPOQ.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1493, doi. 10.1007/s40262-023-01299-3

By:

Zhang, Xiaowei;
Sui, Yu;
Yu, Lei;
Zhou, Min;
Zhang, Chong;
Liu, Danhua;
Chen, Xinren;
Yang, Liqun;
Sui, Yang

Publication type:

Article

Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1333, doi. 10.1007/s40262-023-01293-9

By:

van der Kleij, Maud B. A.;
Guchelaar, Niels A. D.;
Mathijssen, Ron H. J.;
Versluis, Jurjen;
Huitema, Alwin D. R.;
Koolen, Stijn L. W.;
Steeghs, Neeltje

Publication type:

Article

Pharmacokinetics and Pharmacodynamics of Patisiran in Patients with hATTR Amyloidosis and with Polyneuropathy After Liver Transplantation.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1509, doi. 10.1007/s40262-023-01292-w

By:

Badri, Prajakta;
Habtemariam, Bahru;
Melch, Megan;
Clausen, Valerie A.;
Arum, Seth;
Li, Xingyu;
Jay, Patrick Y.;
Vest, John;
Robbie, Gabriel J.

Publication type:

Article

Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1445, doi. 10.1007/s40262-023-01289-5

By:

Chandasana, Hardik;
Thapar, Mita;
Hayes, Siobhan;
Baker, Mark;
Gibb, Diana M.;
Turkova, Anna;
Ford, Deborah;
Ruel, Theodore;
Wiznia, Andrew;
Fairlie, Lee;
Bwakura-Dangarembizi, Mutsa;
Mujuru, Hilda;
Alvero, Carmelita;
Farhad, Mona;
Hazra, Rohan;
Townley, Ellen;
Buchanan, Ann;
Bollen, Pauline;
Waalewijn, Hylke;
Colbers, Angela

Publication type:

Article

Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1427, doi. 10.1007/s40262-023-01288-6

By:

Björnsson, Marcus;
Acharya, Chayan;
Strandgården, Kerstin;
Tiberg, Fredrik

Publication type:

Article

Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1413, doi. 10.1007/s40262-023-01286-8

By:

Wang, Kun;
Feng, Lingge;
Zhang, Jiayi;
Zou, Quanfei;
Xu, Fengyan;
Sun, Zhongyi;
Tang, Fuxing;
Chen, Li

Publication type:

Article

Mirikizumab Pharmacokinetics in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase III LUCENT Studies.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1479, doi. 10.1007/s40262-023-01281-z

By:

Chua, Laiyi;
Friedrich, Stuart;
Zhang, Xin Cindy

Publication type:

Article

Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1461, doi. 10.1007/s40262-023-01274-y

By:

Kluwe, Franziska;
Michelet, Robin;
Huisinga, Wilhelm;
Zeitlinger, Markus;
Mikus, Gerd;
Kloft, Charlotte

Publication type:

Article